Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Safilo Group SpASAFLF 57 Equity-to-Asset is 0.58 as of Jun. 2026, which is 32% above its 10-year median of 0.44. GuruFocus rates SAFLF with a GF Score™ of 57/100 and a GF Value™ of $1.39 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 851 Medical Devices & Instruments companies, Safilo Group SpA ranks worse than 58.05% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Safilo Group SpA's Total Stockholders Equity for the quarter that ended in Jun. 2026 was $548 Mil. Safilo Group SpA's Total Assets for the quarter that ended in Jun. 2026 was $940 Mil.
Therefore, Safilo Group SpA's Equity to Asset Ratio for the quarter that ended in Jun. 2026 was 0.58.
The historical rank and industry rank for Safilo Group SpA's Equity-to-Asset or its related term are showing as below:
SAFLF'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.16 Med: 0.44 Max: 0.58
Current: 0.58
During the past 13 years, the highest Equity to Asset Ratio of Safilo Group SpA was 0.58. The lowest was 0.16. And the median was 0.44.
SAFLF's Equity-to-Asset is ranked worse than 58.05% of 851
companies
in the Medical Devices & Instruments industry
Industry Median: 0.64
vs SAFLF: 0.58
Safilo Group SpA (OTCPK:SAFLF) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Safilo Group SpA Equity-to-Asset Related Terms
Safilo Group SpA Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Safilo Group SpA's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SAFLF vs ISRG, BDX, MDLN: Equity-to-Asset Comparison
For the Medical Instruments & Supplies subindustry, Safilo Group SpA's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Safilo Group SpA Equity-to-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Safilo Group SpA's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Safilo Group SpA's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Safilo Group SpA's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Safilo Group SpA (SAFLF) has a Equity-to-Asset of 0.58 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Safilo Group SpA and its competitors. This is 32% above median its historical median of 0.44. Over the past decade, Safilo Group SpA's Equity-to-Asset has ranged from 0.16 to 0.58. According to the industry distribution chart, Safilo Group SpA ranks #494 out of 851 companies in the Medical Devices & Instruments industry, placing it in the top 58%.
Is Safilo Group SpA's Equity-to-Asset too high?
Safilo Group SpA's current Equity-to-Asset of 0.58 is 32% above median its 10-year median of 0.44. Over the past 10 years, this metric has ranged from a low of 0.16 to a high of 0.58. The Medical Devices & Instruments industry median Equity-to-Asset is 0.64. Safilo Group SpA's value of 0.58 is 9.4% below this industry median. Based on the distribution chart, Safilo Group SpA ranks #494 out of 851 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Safilo Group SpA has a GF Score™ of 57/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Safilo Group SpA's Equity-to-Asset compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Safilo Group SpA ranks #494 out of 851 companies for Equity-to-Asset. This places Safilo Group SpA in the lower half of its industry. The industry median Equity-to-Asset is 0.64. Safilo Group SpA's value of 0.58 is 9.4% below this benchmark. Historically, Safilo Group SpA's own Equity-to-Asset has ranged from 0.16 to 0.58 over the past decade. While the company's 10-year median is 0.44 vs. the industry median of 0.64, Safilo Group SpA has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Medical Devices & Instruments company?
The median Equity-to-Asset among Medical Devices & Instruments companies is 0.64, based on 851 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Safilo Group SpA's current Equity-to-Asset of 0.58 is 9.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Safilo Group SpA and its competitors. For the Medical Devices & Instruments industry, the median Equity-to-Asset is 0.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Safilo Group SpA's current Equity-to-Asset is 0.58, which is 32% above median its own 10-year median of 0.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Safilo Group SpA stock overvalued right now?
Based on GuruFocus' analysis, Safilo Group SpA (SAFLF) is currently considered Significantly Overvalued. The stock's GF Value™ is $1.39, compared to a current price of $2.58 — trading 85.3% above its estimated fair value. The current Equity-to-Asset is 0.58, which is 32% above median its 10-year median of 0.44 and 9.4% below the Medical Devices & Instruments industry median of 0.64. Safilo Group SpA's overall GF Score™ is 57/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Safilo Group SpA (SAFLF), the current Equity-to-Asset is 0.58 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Safilo Group SpA (SAFLF) Overvalued in 2026?
Based on GuruFocus' analysis, Safilo Group SpA stock appears to be overvalued.
The current stock price of $2.58 is trading 85.3% above its estimated GF Value™ of $1.39.
GuruFocus considers Safilo Group SpA to be Significantly Overvalued.
Key valuation signals for SAFLF:
Equity-to-Asset: 0.58 (32% above median its 10-year median of 0.44)
GF Value™: $1.39 vs. price of $2.58 (85.3% above fair value)
Industry Position: 9.4% below the Medical Devices & Instruments median (#494 of 851)
No single metric tells the full story. See the SAFLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Safilo Group SpA makes sunglasses and prescription eyewear. It is engaged in design, production, and wholesale distribution of its products through a network of independent distributors and commercial subsidiaries. Its products are sold through the Carrera, Smith, Polaroid and Oxydo brands, as well as a range of other licensed brands. The company operates solely through the wholesale segment channels and divides itself into the following four geographical segments: Europe, America, and Asia. The company earns the majority of its revenue from the Europe business segment.
57GF Score
Get the complete analysis for SAFLF
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAFLF has been successfully added to your 
